(S,R,S)-AHPC
(S,R,S)-AHPC is a highly selective E3 ligase ligand designed for use in PROTAC (Proteolysis Targeting Chimera) technology. As a derivative of von Hippel-Lindau (VHL) ligand, (S,R,S)-AHPC facilitates the recruitment of VHL E3 ubiquitin ligase, enabling targeted protein ubiquitination and subsequent proteasomal degradation. Belonging to the category of E3 Ligase Ligands, (S,R,S)-AHPC is an essential chemical tool for researchers working on PROTAC drug development and targeted protein degradation platforms. Typical applications include conjugation to various target-binding moieties to develop VHL-based PROTAC molecules for studying, regulating, or degrading disease-associated proteins. This compound accelerates the discovery of next-generation therapeutics across oncology, neuroscience, and other disease areas where precise protein knockdown is paramount.
Structure of 1448297-52-6
Assurance
Delivery
Support
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 100 mg | $293 | In stock | |
| 1 g | $999 | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
- Comprehensive PROTAC Platform
- Scientific Expertise & Technical Support
- Custom Synthesis & Design Service
- Extensive Product Coverage
- Cutting-Edge Innovation
- Fast Delivery & Global Support
- 24/7 customer service
- 100% quality assurance
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC is a highly specialized ligand designed for recruiting the von Hippel-Lindau (VHL) E3 ubiquitin ligase, a central component in the ubiquitin-proteasome system (UPS). VHL ligands like (S,R,S)-AHPC are widely utilized in the construction of PROTACs (Proteolysis Targeting Chimeras), enabling selective protein degradation via VHL-mediated ubiquitination pathways. The (S,R,S) stereochemistry of AHPC ensures optimal binding affinity and specificity for the VHL protein, making it a cornerstone moiety for advanced targeted protein degradation strategies.
Mechanism
(S,R,S)-AHPC functions by specifically binding to the VHL E3 ligase, facilitating its recruitment within bifunctional molecules such as PROTACs. Upon conjugation to a ligand that binds a protein of interest, the PROTAC molecule brings the target protein in proximity to the VHL E3 ligase complex. This interaction triggers polyubiquitination of the target protein, marking it for recognition and degradation by the cell's 26S proteasome. The (S,R,S)-stereochemistry is critical for maximizing potency and maintaining selectivity toward the VHL binding pocket, improving the efficacy of the resultant degraders.
Applications
(S,R,S)-AHPC is a core building block for the synthesis of VHL-based PROTACs and targeted protein degradation tools. Its robust chemical properties and well-characterized binding capacity make it an ideal choice for researchers aiming to develop next-generation degraders for basic research or therapeutic applications. Main uses include:
• Construction of VHL-recruiting PROTACs for preclinical and clinical research• Development of chemical probes to study protein function through selective degradation
• SAR optimization in drug discovery pipelines aimed at undruggable targets
• Custom synthesis projects in academic and pharmaceutical settings
• Exploration of targeted protein degradation as an alternative to classical inhibition
• Consistent batch-to-batch reproducibility with complete QC documentation
• Supplied with COA, MSDS, and analytical data for traceability
• Reliable global shipping with stability-guaranteed packaging
• Dedicated technical support and optional custom synthesis service
• Demonstrates strong binding affinity to CRBN, VHL, or other E3 ligases
• Enables stable E3 ligase recruitment for targeted protein degradation
• Highly selective VHL E3 ligase ligand enables precise and efficient targeted protein degradation in PROTAC applications.
• Well-characterized structure offers reproducible results and broad compatibility with various warheads for customizable PROTAC design.
What is the activity of (S,R,S)-AHPC?
(S,R,S)-AHPC is a VHL ligand that can be used to synthesize PROTAC molecules as part of the recruitment of Von Hippel-Lindau (VHL) proteins.
28/6/2022
PROTAC synthesis
I used (S,R,S)-AHPC as a starting material to synthesize GMB-475 and tested the level of degradation of BCR-ABL1 induced by GMB-475. The experiment is going well!
28/8/2022
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Related Product Recommendations
Please contact us with any specific requirements and we will get back to you as soon as possible.





